Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-15-001421
Filing Date
2015-04-15
Accepted
2015-04-14 18:00:15
Documents
11
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1824988
2 ex31-1.htm EX-31.1 15844
3 ex31-2.htm EX-31.2 15861
4 ex32-1.htm EX-32.1 9582
5 image_002.jpg GRAPHIC 3113
  Complete submission text file 0001493152-15-001421.txt   7455074

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE trgm-20141231.xml EX-101.INS 818189
7 XBRL SCHEMA FILE trgm-20141231.xsd EX-101.SCH 57740
8 XBRL CALCULATION FILE trgm-20141231_cal.xml EX-101.CAL 81466
9 XBRL DEFINITION FILE trgm-20141231_def.xml EX-101.DEF 192925
10 XBRL LABEL FILE trgm-20141231_lab.xml EX-101.LAB 423046
11 XBRL PRESENTATION FILE trgm-20141231_pre.xml EX-101.PRE 325491
Mailing Address 2980 BEVERLY GLEN CIRCLE SUITE 301 LOS ANGELES CA 90077
Business Address 2980 BEVERLY GLEN CIRCLE SUITE 301 LOS ANGELES CA 90077 310-474-9809
Targeted Medical Pharma, Inc. (Filer) CIK: 0001420030 (see all company filings)

EIN.: 205863618 | Fiscal Year End: 1209
Type: 10-K | Act: 34 | File No.: 000-53071 | Film No.: 15770132
SIC: 2834 Pharmaceutical Preparations